ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,240Medicare Part D Prescriptions Filled, Including Refills

Rank: 109 out of 676

$782K Total Retail Price of All Prescriptions

Rank: 101 out of 676

453 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 453 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 13,268 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
OMEPRAZOLE 501 462 1 2
AMLODIPINE BESYLATE 468 416 2 3
FUROSEMIDE 433 402 3 4
HYDROCHLOROTHIAZIDE 403 319 4 12
POTASSIUM CHLORIDE 371 332 5 9
SYNTHROID 304 261 6 48
METFORMIN HCL ER 300 228 7 63
HYDROCODONE-ACETAMINOPHEN 290 227 S3 8 1
LOVASTATIN 289 210 9 33
PRAVASTATIN SODIUM 280 262 10 11
LEVOTHYROXINE SODIUM 277 253 11 7
CARVEDILOL 273 227 12 15
RAMIPRIL 262 226 13 86
CITALOPRAM HBR 261 225 14 17
METOPROLOL SUCCINATE 244 231 15 14
ATORVASTATIN CALCIUM 237 178 16 20
LISINOPRIL 206 172 17 5
WARFARIN SODIUM 206 170 17 18
SIMVASTATIN 202 169 19 6
ZOLPIDEM TARTRATE 195 179 20 21
NAMENDA 186 186 21 35
SERTRALINE HCL 185 185 22 26
METFORMIN HCL 184 131 23 8
MELOXICAM 183 148 24 13
LOSARTAN POTASSIUM 174 174 25 34
METOPROLOL TARTRATE 170 138 26 22
CRESTOR 165 154 27 29
NEXIUM 156 126 28 23
DIOVAN 156 125 28 37
GABAPENTIN 144 140 30 10
ISOSORBIDE MONONITRATE ER 124 109 31 54
COUMADIN 122 101 32 193
DONEPEZIL HCL 113 113 33 24
TAMSULOSIN HCL 112 97 34 38
FENOFIBRATE 112 95 34 90
GLIMEPIRIDE 112 108 34 30
CEPHALEXIN 108 99 37 84
AMOXICILLIN 106 88 38 105
TRAMADOL HCL 104 92 39 19
LANTUS 101 59 40 55
BENAZEPRIL HCL 99 91 41 58
LIPITOR 99 78 41 94
RANITIDINE HCL 93 83 43 27
CLOPIDOGREL 90 76 44 28
TRIAMTERENE-HCTZ 89 76 45 43
LOSARTAN-HYDROCHLOROTHIAZIDE 86 54 46 51
EVISTA 82 82 47 119
PLAVIX 81 75 48 40
DIGOXIN 77 66 49 52
TRICOR 77 77 49 126
ALLOPURINOL 75 61 51 31
MECLIZINE HCL 74 67 52 83
CIPROFLOXACIN HCL 73 65 53 45
ZETIA 72 72 54 89
MIRTAZAPINE 69 69 55 59
RISPERIDONE 68 68 56 69
CYCLOBENZAPRINE HCL 67 63 R 57 50
KLOR-CON 10 65 65 58 95
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 57 58 16
SPIRONOLACTONE 65 49 58 62
DIOVAN HCT 64 58 61 41
CLONIDINE HCL 62 45 62 32
PHENYTOIN SODIUM EXTENDED 60 48 63 88
CEFPROZIL 60 50 63 202
EXELON 57 57 65 130
COLCRYS 56 45 66 122
VYTORIN 56 52 66 176
DILTIAZEM 24HR CD 55 47 68 152
AMLODIPINE BESYLATE-BENAZEPRIL 54 53 69 44
PAROXETINE HCL 53 53 70 65
DOXYCYCLINE HYCLATE 52 49 71 82
POLYETHYLENE GLYCOL 3350 51 40 72 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 7, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.